• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disturbed metabolism of guanidino compounds characterized by elevated excretion of beta-guanidinopropionic acid and gamma-guanidinobutyric acid--an effect of vigabatrin treatment?

作者信息

Schulze A, Mayatepek E, Frank S, Marescau B, De Deyn P P, Bachert P

机构信息

Division of Metabolic Diseases, University Children's Hospital, Heidelberg, Germany.

出版信息

J Inherit Metab Dis. 1998 Jun;21(3):268-71. doi: 10.1023/a:1005376307471.

DOI:10.1023/a:1005376307471
PMID:9686372
Abstract
摘要

相似文献

1
Disturbed metabolism of guanidino compounds characterized by elevated excretion of beta-guanidinopropionic acid and gamma-guanidinobutyric acid--an effect of vigabatrin treatment?
J Inherit Metab Dis. 1998 Jun;21(3):268-71. doi: 10.1023/a:1005376307471.
2
Aminoaciduria resulting from vigabatrin administration in children with epilepsy.
Pediatr Neurol. 1999 Jul;21(1):460-3. doi: 10.1016/s0887-8994(99)00022-3.
3
Fatal hepatotoxicity in a child treated with vigabatrin.
Acta Neurol Scand. 1996 May;93(5):380-1. doi: 10.1111/j.1600-0404.1996.tb00013.x.
4
Vigabatrin.氨己烯酸
Semin Pediatr Neurol. 1997 Mar;4(1):43-50. doi: 10.1016/s1071-9091(97)80008-3.
5
[New antiepileptic drugs: vagabatrin, lamotrigine and felbamate].新型抗癫痫药物：氨己烯酸、拉莫三嗪和非氨酯
Neurologia. 1994 Nov;9(9):410-7.
6
Adverse effects of vigabatrin in Angelman syndrome.氨己烯酸在天使综合征中的不良反应。
Epilepsia. 1998 Nov;39(11):1213-5. doi: 10.1111/j.1528-1157.1998.tb01314.x.
7
Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
Schweiz Arch Neurol Psychiatr (1985). 1995;146(2):55-9.
8
Vigabatrin and complex partial status.氨己烯酸与复杂部分性癫痫持续状态
Seizure. 1994 Mar;3(1):79-80. doi: 10.1016/s1059-1311(05)80168-2.
9
Retrospective study of vigabatrin and psychiatric behavioural disturbances.丙戊酸与精神行为障碍的回顾性研究
Epilepsy Res. 1995 Jul;21(3):227-30. doi: 10.1016/0920-1211(95)00022-3.
10
Pharmacokinetic and pharmacodynamic drug interactions during treatment with vigabatrin.使用氨己烯酸治疗期间的药代动力学和药效学药物相互作用。
Acta Neurol Scand Suppl. 1995;162:43-6. doi: 10.1111/j.1600-0404.1995.tb00500.x.

引用本文的文献

1
Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use-limiting visual field defects.抗癫痫药物氨己烯酸的临床前组织分布与代谢相关性研究及其对视功能限制相关潜在副作用的影响
Pharmacol Res Perspect. 2019 Jan 7;7(1):e00456. doi: 10.1002/prp2.456. eCollection 2019 Feb.
2
Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization.行为代谢组学分析确定了甲基苯丙胺致敏中的新型神经化学特征。
Genes Brain Behav. 2013 Nov;12(8):780-91. doi: 10.1111/gbb.12081. Epub 2013 Sep 30.
3
Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

本文引用的文献

1
Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism.胍基乙酸甲基转移酶缺乏所致肌酸缺乏综合征：一种新型先天性代谢缺陷的诊断工具
J Pediatr. 1997 Oct;131(4):626-31. doi: 10.1016/s0022-3476(97)70075-1.
2
Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.20%至90%肾切除大鼠的胍基化合物代谢
Kidney Int. 1995 Feb;47(2):464-72. doi: 10.1038/ki.1995.59.
3
Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency.
琥珀酸半醛脱氢酶：生化-分子-临床疾病机制、氧化还原调控及功能意义。
Antioxid Redox Signal. 2011 Aug 1;15(3):691-718. doi: 10.1089/ars.2010.3470. Epub 2011 Apr 10.
4
Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development.胚胎期琥珀酸半醛脱氢酶（SSADH）缺乏症中的神经递质改变表明，发育过程中存在兴奋性增强的状态。
BMC Dev Biol. 2008 Nov 28;8:112. doi: 10.1186/1471-213X-8-112.
未透析的肾功能不全患者血清和脑脊液中的胍基化合物。
Clin Chim Acta. 1987 Jul 30;167(1):81-8. doi: 10.1016/0009-8981(87)90088-x.
4
Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy.胍基化合物分析作为高精氨酸血症的补充诊断参数：治疗期间胍基化合物水平的随访
Pediatr Res. 1990 Mar;27(3):297-303. doi: 10.1203/00006450-199003000-00020.
5
Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals.人类及一些排尿素动物的血清、尿液、肝脏、肾脏和大脑中的胍基化合物。
Metabolism. 1992 May;41(5):526-32. doi: 10.1016/0026-0495(92)90213-t.
6
Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice.尿毒症胍类化合物的惊厥作用和毒性：成年小鼠的行为评估及其与脑内浓度的关系
J Neurol Sci. 1992 Oct;112(1-2):96-105. doi: 10.1016/0022-510x(92)90138-b.
7
gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice.γ-乙烯基 GABA（4-氨基-5-己烯酸），一种新型的 GABA-T 选择性不可逆抑制剂：对小鼠脑内 GABA 代谢的影响
J Neurochem. 1977 Nov;29(5):797-802. doi: 10.1111/j.1471-4159.1977.tb10721.x.